However, all these studies targeted MMP9 at later stage of ischemic heart disease or heart failure, while we explored the potential of MMP9 as a useful biomarker for early detection of carotid artery plaques and coronary artery plaques in drug naïve patients with diabetes with subclinical atherosclerotic vascular disease. This evidence concerns the gene MMP9 and diabetes mellitus.